MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma
Open Access
- 21 June 2019
- journal article
- research article
- Published by Tech Science Press in Oncology Research
- Vol. 27 (6) , 691-701
Abstract
Escalating evidence suggests that microRNA-101 (miR-101) is implicated in the development and progression of various cancers, including papillary thyroid carcinoma (PTC). However, the biological function and molecular mechanisms of miR-101 in PTC are still unclear. In this study, we demonstrated that miR-101 expression was significantly decreased in PTC tissues and cell lines. Clinically, a low level of miR-101 was positively associated with advanced histological stages and lymph node and distant metastases. The expression of CXCL12 was negatively correlated with miR-101 level in PTC. CXCL12 was validated as a direct target of miR-101 in PTC cells. Functional experiments proved that miR-101 markedly reduced the proliferation, apoptosis escape, migration, and invasion of PTC cells. Moreover, CXCL12 restoration rescued the suppressive effects of miR-101 on PTC cells by activating Akt- and EMT-associated signaling pathways. Overall, miR-101 exerts oncostatic effects on PTC by downregulating CXCL12 and repressing its downstream Akt and Snail signaling pathways, suggesting that miR-101/CXCL12/Akt or Snail axis may serve as a potential therapeutic target for PTC.Keywords
This publication has 46 references indexed in Scilit:
- Application of Chemokine CXC Motif Ligand 12 as a Novel Diagnostic Marker in Preoperative Fine-Needle Aspiration Biopsy for Papillary Thyroid CarcinomaActa Cytologica, 2013
- MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancersCancer Biology & Therapy, 2012
- Hematopoietic Stem Cell Niche Is a Potential Therapeutic Target for Bone Metastatic TumorsClinical Cancer Research, 2011
- Papillary Thyroid Carcinoma VariantsHead and Neck Pathology, 2011
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses TumorigenicityCancer Research, 2009
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentJournal of Experimental Medicine, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- The functions of animal microRNAsNature, 2004
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004